Get Premium to unlock powerful stock data
Ampio Pharmaceuticals Inc logo

Ampio Pharmaceuticals Inc

$ 0.18 -0.0066 (-3.53%) 08:08 PM EST
P/E:
At Loss
P/B:
1.45
Market Cap:
$ 40.98M
Enterprise V:
$ 9.52M
Volume:
3.78M
Avg Vol (2M):
3.86M
Also Trade In:
Volume:
3.78M
Market Cap $:
40.98M
PE Ratio:
At Loss
Avg Vol (2-Month):
3.86M
Enterprise Value $:
9.52M
PB Ratio:
1.45
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Ampio Pharmaceuticals Inc
NAICS : 325412 SIC : 2834
373 Inverness Parkway, Suite 200, Englewood, CO, USA, 80112
Description
Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and advancement of immunology-based therapies for prevalent inflammatory conditions. Its lead product candidate, Ampion, is in clinical trials and is being developed for the treatment of severe Osteoarthritis of the Knee, an intravenous treatment for COVID-19 patients, and an inhaled treatment for COVID-19 induced respiratory distress.
Name Current Vs Industry Vs History
Cash-To-Debt 36.64
Equity-to-Asset 0.7
Debt-to-Equity 0.03
Debt-to-EBITDA -0.05
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score -5.52
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 4.5
3-Year FCF Growth Rate 20.8
3-Year Book Growth Rate 36.7
Name Current Vs Industry Vs History
5-Day RSI 33.7
9-Day RSI 33.58
14-Day RSI 33.78
6-1 Month Momentum % -74.64
12-1 Month Momentum % -85.64

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.96
Quick Ratio 6.96
Cash Ratio 6.62

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -27

Financials (Next Earnings Date:2022-08-04 Est.)

AMPE's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with AMEX:AMPE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.11
Beta 1.36
Volatility % 59.19
14-Day RSI 33.78
14-Day ATR ($) 0.031372
20-Day SMA ($) 0.22475
12-1 Month Momentum % -85.64
52-Week Range ($) 0.1619 - 1.99
Shares Outstanding (Mil) 227.19

Piotroski F-Score Details

Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Ampio Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More